| Characteristic | Pediatric patients, n = 15 (%) |
| Age (years) | |
| Median | 9.4 |
| Range | 1 - 17.5 |
| Sex | |
| Male | 7 (47) |
| Female | 8 (53) |
| Ethnicity | 12C (80), 1H (7), 1A (7), 1O (7) |
| Tumor Type | |
| Glioblastoma multiforme | 8 (53) |
| Anaplastic astrocytoma | 5 (33) |
| Astrocytoma, grade II, disseminated | 1 (7) |
| Atypical teratoid rhabdoid tumor | 1 (7) |
| Clinical Characteristics | |
| Duration of symptoms prior enrollment | |
| <6 months (%) | 2 (13) |
| >6 months (%) | 13 (87) |
| Prior Treatment | |
| Surgery | 10 (67) |
| Radiation Therapy | |
| One regimen | 11 (73) |
| Two regimens | 1 (7) |
| Chemotherapy | |
| Regimen 1 | 11 (73) |
| Regimen 2 | 1 (7) |
| Regimen 3 | 1 (7) |
| Regimen 5 | 1 (7) |
| Biologics | 2 (13) |
| Targeted Therapy | 1 (7) |